Cardiac Magnetic Resonance Detection of Myocardial Scarring in Hypertrophic Cardiomyopathy. Correlation With Histopathology and Prevalence of Ventricular Tachycardia

Journal of the American College of Cardiology

Volumn 54, Issue 3, 2009, Pages 242-249

  Kwon, Deborah H ^a   Smedira, Nicholas G ^a   Rodriguez, E Rene ^a   Tan, Carmela ^a   Setser, Randolph ^a   Thamilarasan, Maran ^a   Lytle, Bruce W ^a   Lever, Harry M ^a   Desai, Milind Y ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

cardiac magnetic resonance; hypertrophic cardiomyopathy; myocardial scarring; small intramural coronary arteriole dysplasia

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; HEART EJECTION FRACTION; HEART MUSCLE; HEART MUSCLE FIBROSIS; HEART VENTRICLE TACHYCARDIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MUSCLE RESECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SMALL INTRAMURAL CORONARY ARTERIOLE DYSPLASIA;

ADOLESCENT; ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; CONFIDENCE INTERVALS; CORONARY VESSELS; ECHOCARDIOGRAPHY; FEMALE; FIBROSIS; HEART SEPTUM; HUMANS; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIUM; ODDS RATIO; OHIO; PREVALENCE; STROKE VOLUME; TACHYCARDIA, VENTRICULAR; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 67649581000     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.04.026     Document Type: Article

References (30)

1. Maron B.J., Wolfson J.K., Epstein S.E., and Roberts W.C. Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 8 (1986) 545-557
2. Varnava A.M., Elliott P.M., Sharma S., McKenna W.J., and Davies M.J. Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart 84 (2000) 476-482
3. Wu E., Judd R.M., Vargas J.D., Klocke F.J., Bonow R.O., and Kim R.J. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 357 (2001) 21-28
4. Kim R.J., Fieno D.S., Parrish T.B., et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100 (1999) 1992-2002
5. Fieno D.S., Kim R.J., Chen E.L., Lomasney J.W., Klocke F.J., and Judd R.M. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 36 (2000) 1985-1991
6. Moon J.C., Reed E., Sheppard M.N., et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 43 (2004) 2260-2264
7. Moon J.C., Mogensen J., Elliott P.M., et al. Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I. Heart 91 (2005) 1036-1040
8. Choudhury L., Mahrholdt H., Wagner A., et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40 (2002) 2156-2164
9. Moon J.C., McKenna W.J., McCrohon J.A., Elliott P.M., Smith G.C., and Pennell D.J. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41 (2003) 1561-1567
10. Teraoka K., Hirano M., Ookubo H., et al. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. Magn Reson Imaging 22 (2004) 155-161
11. Kwon D.H., Setser R.M., Popovic Z.B., et al. Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study. Int J Cardiovasc Imaging 24 (2008) 617-625
12. Adabag A.S., Maron B.J., Appelbaum E., et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 51 (2008) 1369-1374
13. Martin R.P., Rakowski H., French J., and Popp R.L. Idiopathic hypertrophic subaortic stenosis viewed by wide-angle, phased-array echocardiography. Circulation 59 (1979) 1206-1217
14. Henry W.L., Clark C.E., Griffith J.M., and Epstein S.E. Mechanism of left ventricular outlfow obstruction in patients with obstructive asymmetric septal hypertrophy (idiopathic hypertrophic subaortic stenosis). Am J Cardiol 35 (1975) 337-345
15. Pollick C., Rakowski H., and Wigle E.D. Muscular subaortic stenosis: the quantitative relationship between systolic anterior motion and the pressure gradient. Circulation 69 (1984) 43-49
16. Nakatani S., Marwick T.H., Lever H.M., and Thomas J.D. Resting echocardiographic features of latent left ventricular outflow obstruction in hypertrophic cardiomyopathy. Am J Cardiol 78 (1996) 662-667
17. Maron M.S., Olivotto I., Betocchi S., et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 348 (2003) 295-303
18. Anderson K.P., DeCamilla J., and Moss A.J. Clinical significance of ventricular tachycardia (3 beats or longer) detected during ambulatory monitoring after myocardial infarction. Circulation 57 (1978) 890-897
19. Kellman P., Arai A.E., McVeigh E.R., and Aletras A.H. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med 47 (2002) 372-383
20. Setser R.M., Bexell D.G., O'Donnell T.P., et al. Quantitative assessment of myocardial scar in delayed enhancement magnetic resonance imaging. J Magn Reson Imaging 18 (2003) 434-441
21. Kolipaka A., Chatzimavroudis G.P., White R.D., O'Donnell T.P., and Setser R.M. Segmentation of non-viable myocardium in delayed enhancement magnetic resonance images. Int J Cardiovasc Imaging 21 (2005) 303-311
22. Kwon D.H., Halley C.M., Carrigan T.P., et al. Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study. J Am Coll Cardiol Img 2 (2009) 34-44
23. Roes S.D., Kelle S., Kaandorp T.A., et al. Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction. Am J Cardiol 100 (2007) 930-936
24. Heric B., Lytle B.W., Miller D.P., Rosenkranz E.R., Lever H.M., and Cosgrove D.M. Surgical management of hypertrophic obstructive cardiomyopathy. Early and late results. J Thorac Cardiovasc Surg 110 (1995) 195-206
25. Smedira N.G., Lytle B.W., Lever H.M., et al. Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy. Ann Thorac Surg 85 (2008) 127-133
26. Lorenzoni R., Gistri R., Cecchi F., et al. Coronary vasodilator reserve is impaired in patients with hypertrophic cardiomyopathy and left ventricular dysfunction. Am Heart J 136 (1998) 972-981
27. Petersen S.E., Jerosch-Herold M., Hudsmith L.E., et al. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation 115 (2007) 2418-2425
28. Shirani J., Pick R., Roberts W.C., and Maron B.J. Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol 35 (2000) 36-44
29. Kitamura M., Shimizu M., Ino H., et al. Collagen remodeling and cardiac dysfunction in patients with hypertrophic cardiomyopathy: the significance of type III and VI collagens. Clin Cardiol 24 (2001) 325-329
30. Anderson K.R., Sutton M.G., and Lie J.T. Histopathological types of cardiac fibrosis in myocardial disease. J Pathol 128 (1979) 79-85